|
1
|
Ristic P, Savic M, Bolevich S, Bolevich S, Orlova A, Mikhaleva A, Kartashova A, Yavlieva K, Nikolic Turnic T, Pindovic B, Djordjevic K, Srejovic I, Zivkovic V, Jakovljevic V. Examining the Effects of Hyperbaric Oxygen Therapy on the Cardiovascular System and Oxidative Stress in Insulin-Treated and Non-Treated Diabetic Rats. Animals (Basel) 2023; 13:2847. [PMID: 37760247 PMCID: PMC10525412 DOI: 10.3390/ani13182847] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2023] [Revised: 08/27/2023] [Accepted: 08/29/2023] [Indexed: 09/29/2023] Open
Abstract
BACKGROUND This study explored the effects of hyperbaric oxygen therapy (HBOT) on the cardiovascular system and oxidative stress in streptozotocin-induced diabetic rats. Wistar albino rats were divided into four groups: DM group (diabetic rats), DM+HBOT group (diabetic rats exposed to HBOT for 1 h daily, five days a week, at 2.8 atmosphere absolute (ATA) with 100% oxygen for two weeks), DM+INS group (diabetic rats treated with neutral protamine hagedorn (NPH) insulin at a dosage of 3-5 U/day), and DM+HBOT+INS group (diabetic rats treated with both NPH insulin and HBOT for two weeks). METHODS Evaluations included glycemic control, oxidative stress parameters, and cardiac function measurements. RESULTS NPH insulin treatment reduced blood glucose levels, although normoglycemia was not achieved. The DM+HBOT+INS group demonstrated the lowest pro-oxidative marker levels. NPH insulin treatment improved cardiac function, and combination therapy effectively restored cardiac function in diabetic animals. CONCLUSIONS NPH insulin treatment reduced hyperglycemia and improved cardiac function in diabetic rats. The combined approach of NPH insulin and HBOT resulted in decreased pro-oxidative markers. These findings provide valuable insights for managing cardiovascular complications and oxidative stress in diabetes.
Collapse
Affiliation(s)
- Petar Ristic
- Clinic of Endocrinology, Military Medical Academy, 11000 Belgrade, Serbia;
| | - Maja Savic
- Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia; (T.N.T.); (B.P.); (K.D.)
| | - Sergey Bolevich
- Department of Human Pathology, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia; (S.B.); (S.B.); (A.O.); (A.M.); (A.K.); (K.Y.); (V.J.)
| | - Stefani Bolevich
- Department of Human Pathology, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia; (S.B.); (S.B.); (A.O.); (A.M.); (A.K.); (K.Y.); (V.J.)
- Department of Pathophysiology, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia
| | - Alexandra Orlova
- Department of Human Pathology, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia; (S.B.); (S.B.); (A.O.); (A.M.); (A.K.); (K.Y.); (V.J.)
| | - Anastasiya Mikhaleva
- Department of Human Pathology, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia; (S.B.); (S.B.); (A.O.); (A.M.); (A.K.); (K.Y.); (V.J.)
| | - Anna Kartashova
- Department of Human Pathology, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia; (S.B.); (S.B.); (A.O.); (A.M.); (A.K.); (K.Y.); (V.J.)
| | - Koka Yavlieva
- Department of Human Pathology, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia; (S.B.); (S.B.); (A.O.); (A.M.); (A.K.); (K.Y.); (V.J.)
| | - Tamara Nikolic Turnic
- Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia; (T.N.T.); (B.P.); (K.D.)
- N.A. Semashko Public Health and Healthcare Department, F.F. Erismann Institute of Public Health, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia
| | - Bozidar Pindovic
- Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia; (T.N.T.); (B.P.); (K.D.)
| | - Katarina Djordjevic
- Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia; (T.N.T.); (B.P.); (K.D.)
| | - Ivan Srejovic
- Department of Physiology, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia; (I.S.); (V.Z.)
- Departmennt of Pharmacology, Institute of Biodesign and Complex System Modeling, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia
| | - Vladimir Zivkovic
- Department of Physiology, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia; (I.S.); (V.Z.)
- Departmennt of Pharmacology, Institute of Biodesign and Complex System Modeling, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia
| | - Vladimir Jakovljevic
- Department of Human Pathology, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia; (S.B.); (S.B.); (A.O.); (A.M.); (A.K.); (K.Y.); (V.J.)
- Department of Physiology, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia; (I.S.); (V.Z.)
| |
Collapse
|